Nature Reviews Nephrology

Article	Citations
A UMOD variant with intermediate effects	838
Making advance care planning easier for adults with kidney disease and their clinicians	722
Mentorship in the lives of scholars	482
Engineered CAR macrophages target kidney inflammation	476
Role of the gut microbiota in the pathogenesis of IgA nephropathy	436
The changing landscape of kidney health and disease in Africa	410
Inhibitory effects of oestradiol on ferroptosis may underlie sex differences in AKI	410
Kidney health within the broader non-communicable disease agenda	364
The GLP-1 receptor agonist revolution comes to nephrology	314
Disaster preparedness for patients with kidney disease	302
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	289
Vaccination in patients with kidney failure: lessons from COVID-19	239
Uropathogen and host responses in pyelonephritis	233
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease	231
Treatment of chronic kidney disease in older populations	214
Designing acute kidney injury clinical trials	205
Urine as a source of biomarkers and biological knowledge in chronic kidney disease	191
A single-cell atlas of DKD treatment responses	190
Genetic determinants of urine and plasma metabolite levels	175
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	173
The continued odyssey to unravel the secrets of kidney inflammation	171
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	168
Strategic rebalancing of kidney-related investments is key to implementing the WHO kidney health resolution	164
Consideration of sex differences is necessary to achieve health equity	158
Beyond state borders: transforming dialysis care for undocumented immigrants	158

Roles of sensory receptors in non-sensory organs: the kidney and beyond	153
Phosphate sensing via PTC glycolysis	146
Complosome — the intracellular complement system	146
Mutational signatures of ccRCC vary between geographical regions	141
Bringing Pride to nephrology	140
20 years of Nature Reviews Nephrology	136
Informing clinical decision making during a pandemic — a call for better preparedness	133
Reducing preventable acute kidney injury in a hospital setting	133
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	130
The effects of sex hormone therapy on kidney function	117
Clonal haematopoiesis and AKI	113
Aquaporin water channels: roles beyond renal water handling	107
Menopause and chronic kidney disease	107
Interferon blockade in lupus: effects on antiviral immunity	106
Increasing diversity and inclusion in nephrology clinical trials	94
The roles of hyaluronan in kidney development, physiology and disease	94
Design of a renal-sparing antifungal	89
NUAK1 promotes kidney fibrosis	88
Treatment of SLE with anti-CD19 CAR-T cells	87
Benefits of actin cytoskeleton stabilization	85
Heat and health inequity: acting on determinants of health to promote heat justice	83
Identification of erythropoietin-producing cells	82
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	82
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	77
From fat to filter: the effect of adipose tissue-derived signals on kidney function	77
Long-term health outcomes associated with hydration status	76
Tertiary lymphoid organs contribute to kidney allograft rejection	76
Salt substitution: opportunities and challenges for nephrology	73
Pathological mechanisms of kidney disease in ageing	71
The role of complement in kidney disease	70
Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure	70
Neutrophils and NETs in kidney disease	69
Reaping the rewards of mechanistic discovery in glomerular disease	69
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	68
The evolving landscape of immune-mediated glomerular diseases	67
A pathway of osmotic stress-induced necroptosis	67
A golden year of innovative kidney disease therapeutics	67
MSC therapy for diabetic kidney disease and nephrotic syndrome	66
An integrated approach towards a public health perspective on chronic kidney disease	64
Patient-centred approaches for the management of unpleasant symptoms in kidney disease	62
Network medicine: an approach to complex kidney disease phenotypes	62
Combination therapy for kidney disease in people with diabetes mellitus	62
A label-free optical analysis for molecular nephrology	62
Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	62
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	59
Consequence of microvascular inflammation in transplantation	57
Transcatheter mitral valve repair in patients with CKD	56
CKD-specific ASCVD risk prediction tools	56
Consequences of famine and malnourishment on kidney health	56
PDGFRβ CAR T cells improve fibrosis in kidney disease models	56

GalNAc-T14-associated defects in B cell homing in IgA nephropathy	56
Ketogenic diet benefits in critically ill patients with sepsis	56
Continuing kidney care in conflicts	55
Long COVID and the kidney	53
Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors	52
The cilia mechanosensation debate gets (bio)physical	51
Kidney complications of parasitic diseases	51
Role of the cGAS–STING pathway in systemic and organ-specific diseases	50
Dietary protection of proximal tubules in diabetes	48
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia	48
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	48
Mechanism of B cell survival in lupus nephritis	45
Gene therapy in a model of nephrotic syndrome	42
Multifaceted innovations needed to advance transplant nephrology	40
Mannose as a driver of γδ T cell kidney infiltration	40
IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxis	38
A guide to gene–disease relationships in nephrology	38
The kidney is a novel target of metformin	38
Epithelial cell states associated with kidney and allograft injury	38
Targeting IL-1Ra to attenuate fungal infection	37
Generation of self-assembling kidney progenitor assembloids	36
The genetics of hypertension	36
Steps forward in the treatment of IgA nephropathy	36
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	35
Metabolic alterations in hereditary and sporadic renal cell carcinoma	34
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	33
Role of necroptosis in kidney health and disease	33
Born too soon: lifelong kidney risks and the importance of early intervention	33
A multidisciplinary approach to cardiorespiratory fitness in CKD	32
Fasting induces structural and functional changes in the peritoneal membrane	32
Chronic cardiovascular–kidney disorder: a new conceptual framework	32
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	31
Author Correction: Therapeutic advances in COVID-19	31
Derivation of collecting duct organoids	31
ALCAM–CD6 in lupus nephritis	30
Leveraging data as a patient–scientist: frustrations and opportunities	30
Green nephrology: from evidence to action	30
The increasing burden of mild and moderate anaemia in CKD	28
From big data to smart decisions: artificial intelligence in kidney risk assessment	27
Tissue-resident memory T cells in the urogenital tract	26
The perils of misinformation: when health literacy goes awry	26
The immunology of sepsis: translating new insights into clinical practice	25
Strategies to achieve gender equity in nephrology	23
Renal nerves in physiology, pathophysiology and interoception	23
Insights into the impact of pregnancy on kidney disease	23
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	22
A guide to uraemic toxicity	22
Acute kidney injury in patients with burns	22
The impact of intrauterine growth restriction and prematurity on nephron endowment	22
Switching off SOX9 for epithelial recovery after AKI	21
Fibroblast activation and heterogeneity in fibrotic disease	21
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	21
CD38 — a new target in renal immune disease	20
The impact of population ageing on the burden of chronic kidney disease	20
Digital determinants of health: opportunities and risks amidst health inequities	19
Crosstalk between glomeruli and tubules	19
Hope for resistant hypertension through BrigHTN and PRECISION	19
Impact of persistent conflict and destabilizing events on dialysis care	19
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	19
Bridging the gap of referral to nephrology care	18
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup	18
Nephrology and women’s health post-Roe v. Wade: we must do better	18
Collagen formation, function and role in kidney disease	18
Application of spatial-omics to the classification of kidney biopsy samples in transplantation	17
Kidney transplants: from antigen recognition to targeted therapy	16
Podocyte-targeted therapies — progress and future directions	16
Pathogenic cellular and molecular mediators in lupus nephritis	16
Improving the quality of pharmacoepidemiological studies using the target trial emulation framework	16
Deep learning applications in digital pathology	16
A year of disruption and progress in kidney health policy	16
Cellular senescence: the good, the bad and the unknown	15
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis	15
Anti-tumour antibody-producing plasma cells disseminate from tertiary lymphoid structures	15
Increased PD1 signalling in kidney ageing	14
mTORC1 under the control of CB1R	14
Use of kidneys from SARS-CoV-2 infected donors	14
P3H2 in glomerular basement membrane regulation	14
Belzutifan: a novel therapy for von Hippel–Lindau disease	13
Progress towards solving the donor organ shortage	13
Lived experience and empathy: lessons learned as a nephrologist with kidney disease	13

Publisher Correction: Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	13
Trained immunity: from kidney failure to organ transplantation	13
Advances and challenges in kidney fibrosis therapeutics	12
The evolving story of apolipoprotein L1 nephropathy: the end of the beginning	12
New evidence of the impact of mitochondria on kidney health and disease	12
Vascular damage in systemic lupus erythematosus	12
New and emerging therapies for diabetic kidney disease	12
Important roles of mechanical force and hydraulic pressure in kidney function	11
Gasdermins and pyroptosis in the kidney	11
Author Correction: Beyond state borders: transforming dialysis care for undocumented immigrants	11
TRPM channels in health and disease	11
Incorporating dementia screening in the care of patients with kidney disease	11
Pharmacogenomics in the clinic	11
Insights into glomerular function and disease pathogenesis	11
SGLT2 inhibitors may prevent diabetes	10
Advances in risk prediction and treatment strategies for CKM syndrome	10
The impact of the Russian–Ukrainian war for people with chronic diseases	10
Thiazides in kidney transplant recipients: skin in the game	10
Cell and gene therapy for kidney disease	9
Clonal haematopoiesis, ageing and kidney disease	9
Anti-nephrin autoantibodies: a paradigm shift in podocytopathies	9
Cystatin C and the misdiagnosis of CKD in older adults	9
Kidney health outcomes of hypertensive disorders of pregnancy	9
Inflammation and gut dysbiosis as drivers of CKD–MBD	9
Advancing gender equity to improve kidney care for women: a patient perspective	8
Electronic patient-reported outcomes in chronic kidney disease	8
Youth-onset type 2 diabetes mellitus: an urgent challenge	8
Kidney and heart failure outcomes associated with SGLT2 inhibitor use	8
Diuretics in patients with chronic kidney disease	8
ECM remodelling by ADAMTS12 in fibrosis	8
Progress in xenotransplantation: overcoming immune barriers	8
Disasters and kidney care: pitfalls and solutions	8
The genetics and pathogenesis of CAKUT	8
Patient involvement in nephrology research	8
Epidemiology of haemodialysis outcomes	8
The role of lysosomes in metabolic and autoimmune diseases	7
Chronic kidney disease and the global public health agenda: an international consensus	7
Advances in CRISPR therapeutics	7
Including sexual orientation and gender identity data to advance nephrology care	6
Circulating osteopontin mediates acute kidney injury-induced respiratory failure	6
Diagnosis of cardiovascular disease in patients with chronic kidney disease	6
Drug repurposing for glomerular diseases: an underutilized resource	6
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential	6
Remodelling by macula densa cells	6
The pathogenesis of pre-eclampsia in kidney donors	6
New insights into kidney crosstalk with distant organs	6
Synchronization in the renal microcirculation	6
Intersectionality as a lens for achieving kidney health justice	6
Long-term lessons from EMPA-KIDNEY	6
A guide to studying 3D genome structure and dynamics in the kidney	6
Amino acid metabolism in kidney health and disease	5
Avenciguat reduces albuminuria in patients with chronic kidney disease	5
Removal of small, asymptomatic kidney stones	5
Inequities in kidney health and kidney care	5
Renoprotective effects of sparsentan: clinical trial evidence in IgA nephropathy and FSGS	5
The intelligent podocyte: sensing and responding to a complex microenvironment	5
The catastrophic costs of chronic kidney disease	5
Paths to organ damage and risk factors in AKI	5
The slit diaphragm has a conserved fishnet architecture	5
Post-translational modifications in kidney diseases and associated cardiovascular risk	5
From resolution to reality: advancing point-of-care diagnostics for kidney disease in low-resource settings	4
Iron deficiency of kidney macrophages in CKD	4
Sexual orientation and gender identity in organ and tissue donation and transplantation	4
Interactive exploration of multimodal spatial data with FUSION	4
The kidney stroma in development and disease	4
Leveraging lysine metabolism for renoprotection	4
Protein handling in kidney tubules	4
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia	4
UTX regulates accumulation of lipids via kidney serine	4
A polygenic score predicts CKD across ancestries	4
Sex differences in kidney metabolism and DKD	4
Ensuring health equity for sexual and/or gender minority individuals	4
Association of metabolic dysfunction-associated fatty liver disease with kidney disease	4
NCKs are essential to podocyte–GBM interactions	4
Propagation of acute kidney injury	4
A new pathway links iron sensing with histone demethylation and regulation of mTORC1 activity	4
Improving nephrology care for people with cognitive impairments and their caregivers	4
Cell–cell crosstalk in kidney health and disease	4
Targeting iron uptake to correct T cell dysfunction	4
AngII autoantibodies after SARS-CoV-2 infection	4
Overcoming barriers to deliver high quality kidney care	4
The roles of tertiary lymphoid structures in chronic diseases	4
The pathogenesis of IgA nephropathy and implications for treatment	3
The global landscape of kidney registries: immense challenges and unique opportunities	3
Fiji’s rising tide: the growing burden of diabetic kidney disease on emerging nephrology services	3
A CAAR NK cell approach to eliminate pathogenic autoantibody-secreting cells	3
Spatial transcriptomics in health and disease	3
VHL loss attracts immune cells to tumours	3
New AAV vector targets glomerular endothelial cells	3
Managing RAAS inhibitor use in advanced CKD	3
Artificial intelligence approaches to enable early detection of CKD	3
Targeting perivascular S1P attenuates inflammation	3
Author Correction: The immunoregulatory roles of non-haematopoietic cells in the kidney	3
Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants	3
Insights into basement membrane complexity	3